Skip to end of metadata
Go to start of metadata
Scope and Purpose
To propose steps for creation of LIVD file entries for all IVD tests, available in a centralized repository with or without mapping review. Define the initial design and develop a sustainability and steady state plan for use of LIVD specifically and for other SHIELD standards in the future Ultimate goal is to have data used in patient care, research public health be comparable - need to have support for the full data model for the complete meaning of the test |
Items in scope: Current: Develop a plan for steady state operationally Develop process to add and review new data elements Develop process for submission, optional review and feedback on content Should include a QA process as part of the submission for either new data elements as well as content
financially
Develop and recommend a SHIELD endorsed standards implementation plan Creation of LIVD Catalog by IVD Manufacturers - increase number of manufacturers creating catalog LAW adoption - increase number of instruments supporting IHE LAW Get more of the standards used in SHIELD as part of Recognized Consensus Standards: Medical Devices (fda.gov) currently listed: LOINC, SNOMED, POCT1A missing: UCUM, CLSI AUTO16 / LAW, IHE profiles
Identify mapping content applicable to a LIVD catalog for terminology alignment (this WG definds the elements, the Vocab and Standards identifies the best approach) Identify which of the data elements are needed in the data flow and which are needed for reference within LIDR
Future: Develop LIVD planning roadmap of supporting activities Orders other elements providing clinical context lot numbers (may not be LIDR content, but needed for sending along with result - which WG does this go to?)
LIDR WG Parking Lot |
Items out of scope: Harmonization of lab tests - this is important work for clinical interoperability, but is not terminology related, requires lab studies etc (we are interested in documenting the elements needed to better understand the test results) Information modeling (part of the standards and terminology workgroup) around how data from different tests are put to use in LIS / EHR-s data exchange (part of the IVD data hub working group work) Calculations not performed on the IVD instrument (e.g. Creatinine ratio) (this may be part of the standards and terminology working group) additional assessments made by humans (this may be part of the standards and terminology working group) lot numbers for reagents, preparation steps (stains / extraction kits / dilution etc) = no instance representation
|
Workplan |
Prior work: https://aphlinformatics.atlassian.net/wiki/spaces/SLC |
Every Monday 9-10 AM ET
Join Zoom Meeting
Participants
Name | Organization | Role |
---|
Hung Luu | UT Southwestern Medical Center | Working Group Co-Chair; SC liasion |
Riki Merrick | Association of Public Health Laboratories | Working Group Co-Chair; SC liasion |
Andrea Pitkus | University of Wisconsin-Madison | Steering Committee member |
Xavier Gansel | Biomerieux | Steering Committee member |
Rob Rae | CAP | |
Dan Rutz | Epic | Steering Committee member |
Pam Banning | 3M Health Information Systems | |
Laurent LARDIN | Biomerieux | |
Amy McCormick | Epic | |
Sandy Jones | CDC Cancer Surveillance | |
Stan Huff | Graphite | Steering Committee member |
Craig Collom | | Steering Committee member |
Marti Velezis | Sonrisa/FDA | |
Walter Sujanski | FDA | Observer |
Operational Definitions
Name (Acronym) | Definition |
---|
IVD (in-vitro Diagnostic) Test | |
| |
Projects
Project Name [include link to the filled out project template file, if created] | Brief Description | Priority |
---|
LIVD File Repository Requirements | Compile the requirements for LIDR - functional/policy/starting content/sustainability and develop and document the process for adding NEW | 1 |
Additional data elements for LIVD file (e.g. UDI for equipment/ reagents, harmonization methods, UDIs for devices/kits/reagents | this is defining the WHAT elements are needed in LIDR - it will inform the requirements above, where we need to define the process of HOW to add new elements, when those are identified | 2 |
Clinically relevant test definitions - what makes results “co-minglable” | | 3 |
Action Items
0 Comments